Analyst firms · Citigroup · HOLX
Citigroup HOLX price target and rating history
Hologic Inc. (HOLX) · Health Care
Citigroup rates Hologic Inc. (HOLX) Buy with a $80 price target, as of its latest action on Jul 9, 2025. It has published 4 rating actions on HOLX since December 2021, including 2 upgrades and 2 downgrades.
- Current rating
- Buy
- Price target
- $80
- Median target, all firms
- Too few
- Actions on HOLX
- 4
Citigroup price target on HOLX
Every Citigroup rating on HOLX
- Jul 9, 2025
- Oct 1, 2024
- Apr 3, 2024
- Dec 15, 2021
How other firms rate HOLX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Hold | Jan 12, 2026 | |
| Evercore ISI | In-line | $78 | Jan 5, 2026 |
| BNP Paribas Exane | Neutral | $79 | Nov 21, 2025 |
Questions about Citigroup and HOLX
- What is Citigroup's price target for HOLX?
- Citigroup's latest stated price target for Hologic Inc. (HOLX) is $80, from its action on Jul 9, 2025.
- What is Citigroup's rating on HOLX?
- Citigroup rates HOLX Buy, a bullish rating, as of Jul 9, 2025.
- When did Citigroup last change its view on HOLX?
- On Jul 9, 2025, Citigroup upgrades to Buy from Neutral, price target $80.
More HOLX rating histories
All Citigroup ratingsHOLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.